AMN Healthcare to Present at Three Conferences in November
SAN DIEGO, Oct. 18, 2017 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), healthcare's leader and innovator in workforce solutions and staffing services, is scheduled to present at three upcoming investor conferences:
Credit Suisse 26th Annual Healthcare Conference on November 8, 2017, at 10:25 a.m., at The Phoenician in Scottsdale, Arizona.
J.P. Morgan Ultimate Services Investor Conference 2017 on November 14, 2017, at 1:15 p.m. Eastern Time in the J.P. Morgan office at 383 Madison Avenue, New York.
Stifel 2017 Healthcare Conference on November 15, 2017, at 11:00 a.m. Eastern Time at the Lotte New York Palace Hotel in New York.
Brian Scott, Chief Financial Officer of AMN Healthcare, is presenting at the conferences. An audio webcast and a copy of the investor presentation will be available on the Company's investor relations website at http://amnhealthcare.investorroom.com/presentations on the days of the events. Participants will need to allow adequate time to download any software necessary for the webcast.
About AMN Healthcare AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency, and improve patient outcomes. AMN delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, medical coding and consulting, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, and many other healthcare settings. For more information about AMN Healthcare, visit www.amnhealthcare.com.
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...